Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
34.8M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
27.6M
-
Shares change
-
+5.32M
-
Total reported value, excl. options
-
$1.24B
-
Value change
-
+$213M
-
Put/Call ratio
-
0.34
-
Number of buys
-
81
-
Number of sells
-
-64
-
Price
-
$45.07
Significant Holders of Disc Medicine, Inc. - COMMON STOCK (IRON) as of Q2 2024
173 filings reported holding IRON - Disc Medicine, Inc. - COMMON STOCK as of Q2 2024.
Disc Medicine, Inc. - COMMON STOCK (IRON) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.6M shares
of 34.8M outstanding shares and own 79.24% of the company stock.
Largest 10 shareholders include Paradigm Biocapital Advisors LP (2.7M shares), Atlas Venture Life Science Advisors, LLC (2.51M shares), Bain Capital Life Sciences Investors, LLC (1.8M shares), ORBIMED ADVISORS LLC (1.79M shares), WELLINGTON MANAGEMENT GROUP LLP (1.76M shares), Frazier Life Sciences Management, L.P. (1.75M shares), BlackRock Inc. (1.44M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.12M shares), VANGUARD GROUP INC (1.11M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.02M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.